AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20594096 — intervention group
Group type: COMPARATOR
Intervention: Non‐stage‐tailored education (traditional brochure)
Number of subjects: 408
Study 18774000 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 47
Study 18774000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 16314604 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (up to 50 mg/day for 31 days)
Number of subjects: 120
Study 16314604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 16314604 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 120
Study 12074418 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane and fentanyl
Number of subjects: 59
Study 12074418 — intervention group
Group type: COMPARATOR
Intervention: Dehydrobenzperidol and fentanyl
Number of subjects: 59
Study 9923503 — intervention group
Group type: EXPERIMENTAL
Intervention: Exam group (students participating in a major medical exam)
Number of subjects: 26
Study 9923503 — intervention group
Group type: COMPARATOR
Intervention: Control group (students not participating in any exam)
Number of subjects: 26
Study 7594100 — intervention group
Group type: EXPERIMENTAL
Intervention: Reteplase
Number of subjects: 1398
Study 7594100 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 1398
Study 2315355 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan
Number of subjects: 0
Study 2315355 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study 7431552 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin ophthalmic ointment
Number of subjects: 559
Study 7431552 — intervention group
Group type: COMPARATOR
Intervention: Silver nitrate drops
Number of subjects: 559
Study 6871773 — intervention group
Group type: EXPERIMENTAL
Intervention: Zomepirac 100 mg administered 30 minutes preoperatively
Number of subjects: 60
Study 6871773 — intervention group
Group type: EXPERIMENTAL
Intervention: Zomepirac 100 mg administered one hour preoperatively
Number of subjects: 60
Study 6871773 — intervention group
Group type: EXPERIMENTAL
Intervention: Zomepirac 200 mg administered one hour preoperatively
Number of subjects: 60
Study 6871773 — intervention group
Group type: COMPARATOR
Intervention: Control group (standardized general anaesthetic without narcotic supplementation)
Number of subjects: 60
Study 30831049 — intervention group
Group type: EXPERIMENTAL
Intervention: Songwriting intervention (group-based blues songwriting protocol)
Number of subjects: 118
Study 30831049 — intervention group
Group type: COMPARATOR
Intervention: Control condition (questionnaire before intervention)
Number of subjects: 118
Study 29129608 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative progressive resistance training (PRT)
Number of subjects: 30
Study 27513901 — intervention group
Group type: EXPERIMENTAL
Intervention: PGA monotherapy
Number of subjects: 70
Study 27513901 — intervention group
Group type: EXPERIMENTAL
Intervention: PGA combination regimens
Number of subjects: 70
Study 27513901 — intervention group
Group type: COMPARATOR
Intervention: Non-PGA medications
Number of subjects: 70
Study 27513901 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (not on any topical medications)
Number of subjects: 70
Study 24962242 — intervention group
Group type: EXPERIMENTAL
Intervention: PGB-CR 330 mg
Number of subjects: 323
Study 24962242 — intervention group
Group type: EXPERIMENTAL
Intervention: PGB-CR 165 mg
Number of subjects: 323
Study 24962242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study 22841694 — intervention group
Group type: EXPERIMENTAL
Intervention: Food disgust
Number of subjects: 0
Study 22841694 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-food disgust
Number of subjects: 0
Study 22841694 — intervention group
Group type: COMPARATOR
Intervention: Food control
Number of subjects: 0
Study 22841694 — intervention group
Group type: COMPARATOR
Intervention: Negative emotion control
Number of subjects: 0
Study 20569107 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored feedback report, telephone counseling, and supplementary educational materials focused on smoking cessation and improved nutrition
Number of subjects: 0
Study 17697846 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 0
Study 17697846 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 17697846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16043801 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/d ethyl‐EPA
Number of subjects: 135
Study 16043801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 12138321 — intervention group
Group type: EXPERIMENTAL
Intervention: Padma Lax
Number of subjects: 61
Study 12138321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 10457698 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based vision therapy with supplementary home therapy
Number of subjects: 60
Study 10457698 — intervention group
Group type: EXPERIMENTAL
Intervention: Home therapy only
Number of subjects: 60
Study 10457698 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 7788822 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% N2O/30% O2/halothane
Number of subjects: 320
Study 7788822 — intervention group
Group type: COMPARATOR
Intervention: 100% O2/halothane
Number of subjects: 320
Study 2193628 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 78
Study 2193628 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 78
Study 2193628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 34185 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (daily doses increasing up to 3 g)
Number of subjects: 10
Study 34185 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (mean therapeutic level of 1600 mg/day)
Number of subjects: 10
Study 34185 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (dose increase related to hypertensive encephalopathy)
Number of subjects: 10
Study 31354946 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory spatial training (15 sessions)
Number of subjects: 120
Study 31354946 — intervention group
Group type: COMPARATOR
Intervention: Control group (no auditory spatial training)
Number of subjects: 120
Study 28462609 — intervention group
Group type: EXPERIMENTAL
Intervention: Single pair of gloves
Number of subjects: 41
Study 28462609 — intervention group
Group type: EXPERIMENTAL
Intervention: Double pair of gloves
Number of subjects: 41
Study 28462609 — intervention group
Group type: COMPARATOR
Intervention: No gloves
Number of subjects: 41
Study 26819451 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphopanel sequencing
Number of subjects: 215
Study 26819451 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP treatment in ABC patients
Number of subjects: 215
Study 24332997 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate 325mg daily for 6 weeks
Number of subjects: 22
Study 24332997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 23067321 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily for 12 weeks
Number of subjects: 151
Study 19774310 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-session pool exercise
Number of subjects: 166
Study 19774310 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-session pool exercise (60% participation)
Number of subjects: 166
Study 19774310 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-session pool exercise (long-term follow-up)
Number of subjects: 166
Study 19774310 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-session pool exercise (subgroup analysis)
Number of subjects: 166
Study 19774310 — intervention group
Group type: COMPARATOR
Intervention: Control group (6-session education programme)
Number of subjects: 166
Study 17504996 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 1231
Study 17504996 — intervention group
Group type: COMPARATOR
Intervention: Nonirradiated tumors
Number of subjects: 1231
Study 15202823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile roller pump perfusion using Sarns 8000 roller pump
Number of subjects: 40
Study 15202823 — intervention group
Group type: COMPARATOR
Intervention: Non-pulsatile perfusion
Number of subjects: 40
Study 11530128 — intervention group
Group type: COMPARATOR
Intervention: Estradiol (2 mg continuously during four 28-day cycles) + Medroxyprogesterone acetate (10 mg), Norethindrone acetate (1 mg), or Placebo (last 14 days of each cycle)
Number of subjects: 23
Study 11530128 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg continuously during four 28-day cycles) + Medroxyprogesterone acetate (10 mg), Norethindrone acetate (1 mg)
Number of subjects: 23
Study 15481766 — intervention group
Group type: EXPERIMENTAL
Intervention: E + C (ephedrine 20 mg and caffeine 200 mg) in hypertensive patients treated with antihypertensive agents other than beta-blockers
Number of subjects: 136
Study 15481766 — intervention group
Group type: EXPERIMENTAL
Intervention: E + C in normotensive patients
Number of subjects: 136
Study 15481766 — intervention group
Group type: COMPARATOR
Intervention: Placebo in hypertensive patients under any antihypertensive treatment
Number of subjects: 136
Study 15481766 — intervention group
Group type: COMPARATOR
Intervention: Placebo in normotensive patients
Number of subjects: 136
Study 15481766 — intervention group
Group type: EXPERIMENTAL
Intervention: E + C in all groups
Number of subjects: 136
Study 15481766 — intervention group
Group type: COMPARATOR
Intervention: Placebo in all groups
Number of subjects: 136
Study 8302451 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sodium naproxen (550 mg) immediately after induction of anesthesia (Group I)
Number of subjects: 75
Study 8302451 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sodium naproxen (550 mg) at the end of surgery (Group II)
Number of subjects: 75
Study 8302451 — intervention group
Group type: COMPARATOR
Intervention: Intravenous normal saline immediately after induction of anesthesia (Group III)
Number of subjects: 75
Study 3327697 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nifedipine infusion
Number of subjects: 10
Study 3327697 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nifedipine infusion with additional propranolol
Number of subjects: 10
Study 3327697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31436631 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) over the occipital cortex
Number of subjects: 26
Study 31436631 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) over the cerebellar vermis
Number of subjects: 26
Study 31436631 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS)
Number of subjects: 26
Study 29229652 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised treatment by general practitioners based on pathophysiological phenotyping and individualised treatment goals.
Number of subjects: 0
Study 29229652 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised lifestyle intervention (web-based and face-to-face) to improve daily physical activity and dietary changes.
Number of subjects: 0
Study 29229652 — intervention group
Group type: COMPARATOR
Intervention: Matched control cohort receiving routine clinical care.
Number of subjects: 0
Study 26625119 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of cycle path
Number of subjects: 1232
Study 26625119 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic density
Number of subjects: 1232
Study 26625119 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental maintenance
Number of subjects: 1232
Study 26625119 — intervention group
Group type: EXPERIMENTAL
Intervention: Evenness of cycle path
Number of subjects: 1232
Study 26625119 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed limits
Number of subjects: 1232
Study 23196855 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided group with overlay of 3D CS images on live fluoroscopy
Number of subjects: 17
Study 23196855 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided group
Number of subjects: 17
Study 21722028 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention for DBD
Number of subjects: 84
Study 21722028 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparison (HC) group
Number of subjects: 84
Study 19537014 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized terbutaline
Number of subjects: 35
Study 19537014 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 35
Study 16966110 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (three outpatient treatments with eight needles applied to bilateral points LI4, SP6, UB31, and UB32)
Number of subjects: 56
Study 16966110 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 56
Study 16966110 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care (control group)
Number of subjects: 56
Study 15277739 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerivastatin (C)
Number of subjects: 36
Study 15277739 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin (P)
Number of subjects: 36
Study 10755175 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory integration training
Number of subjects: 16
Study 10755175 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 16
Study 8774286 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg three times per day for > or = 3 days)
Number of subjects: 6
Study 1595317 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen fleece (Lyostypt)
Number of subjects: 100
Study 1595317 — intervention group
Group type: COMPARATOR
Intervention: Gelatine sponge (Marbagelan)
Number of subjects: 100
Study 6086765 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acyclovir
Number of subjects: 309
Study 6086765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study 31178203 — intervention group
Group type: EXPERIMENTAL
Intervention: da Vinci SP robotic system
Number of subjects: 21
Study 29905758 — intervention group
Group type: EXPERIMENTAL
Intervention: SSU hospitalisation
Number of subjects: 430
Study 29905758 — intervention group
Group type: COMPARATOR
Intervention: IMD hospitalisation
Number of subjects: 430
Study 26281857 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Group Therapy (ACT-G)
Number of subjects: 126
Study 26281857 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 126
Study 24911421 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving intervention (PSI) consisting of 2 home visits and 18 telephone calls over a 3-month intensive intervention and a 9-month maintenance period. Both groups received monthly information letters in addition to usual care.
Number of subjects: 122
Study 24911421 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving usual care and monthly information letters.
Number of subjects: 122
Study 22048466 — intervention group
Group type: EXPERIMENTAL
Intervention: varenicline
Number of subjects: 1175
Study 22048466 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 1175
Study 19851115 — intervention group
Group type: EXPERIMENTAL
Intervention: elvitegravir/r (150/100 mg once daily) plus maraviroc (150 mg twice daily)
Number of subjects: 36
Study 19851115 — intervention group
Group type: COMPARATOR
Intervention: maraviroc (150 mg twice daily) before or after elvitegravir/r (150/100 mg once daily)
Number of subjects: 36
Study 19851115 — intervention group
Group type: EXPERIMENTAL
Intervention: elvitegravir/r (150/100 mg once daily)
Number of subjects: 36
Study 18021205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 25
Study 18021205 — intervention group
Group type: COMPARATOR
Intervention: TCA 33% solution
Number of subjects: 25
Study 16027889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell therapy (cell suspension from immature nervous and hemopoietic tissues injected into the subarachnoidal space)
Number of subjects: 30
Study 16027889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell therapy
Number of subjects: 30
Study 12370107 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg finasteride/day
Number of subjects: 56
Study 12370107 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride/day
Number of subjects: 56
Study 10999118 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative percutaneous transhepatic biliary drainage (PTBD)
Number of subjects: 40
Study 10999118 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 40
Study 7672841 — intervention group
Group type: EXPERIMENTAL
Intervention: IMZ implants
Number of subjects: 392
Study 7672841 — intervention group
Group type: COMPARATOR
Intervention: Periotest method
Number of subjects: 392
Study 1315825 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril 10 mg
Number of subjects: 12
Study 1315825 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril 50 mg
Number of subjects: 12
Study 1315825 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril 200 mg
Number of subjects: 12
Study 1315825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3881331 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 20
Study 3881331 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 20
Study 3881331 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 20
Study 3881331 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of cirrhosis and HBeAg
Number of subjects: 20
Study 31306313 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 256
Study 31306313 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational handout
Number of subjects: 256
Study 31306313 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 256
Study 28799232 — intervention group
Group type: EXPERIMENTAL
Intervention: Professionally administered plaque removal (PAPR) and photodynamic therapy (PDT)
Number of subjects: 20
Study 27618939 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Pregnancy project (intervention group)
Number of subjects: 1509
Study 27618939 — intervention group
Group type: COMPARATOR
Intervention: Common practice (control group)
Number of subjects: 1509
Study 23917169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSMZ 17648 (Pylopass™)
Number of subjects: 22
Study 23917169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 22136942 — intervention group
Group type: EXPERIMENTAL
Intervention: Social contact with a depressed individual during psychiatric practical (N=127)
Number of subjects: 127
Study 22136942 — intervention group
Group type: COMPARATOR
Intervention: Compulsory psychiatry practical alone (Control group, N=98)
Number of subjects: 127
Study 19803579 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (3 individual sessions)
Number of subjects: 405
Study 19803579 — intervention group
Group type: COMPARATOR
Intervention: Counseling as usual (3 individual sessions)
Number of subjects: 405
Study 17080375 — intervention group
Group type: EXPERIMENTAL
Intervention: Gauze bandage
Number of subjects: 102
Study 17080375 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive bandage with gauze lining
Number of subjects: 102
Study 17080375 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam bandage
Number of subjects: 102
Study 17080375 — intervention group
Group type: COMPARATOR
Intervention: All bandage types
Number of subjects: 102
Study 15132405 — intervention group
Group type: COMPARATOR
Intervention: Stepper machine
Number of subjects: 14
Study 15132405 — intervention group
Group type: COMPARATOR
Intervention: Skier machine
Number of subjects: 14
Study 15132405 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 14
Study 11709252 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontact tonometry
Number of subjects: 60
Study 11709252 — intervention group
Group type: COMPARATOR
Intervention: Goldmann applanation tonometry
Number of subjects: 60
Study 11709252 — intervention group
Group type: COMPARATOR
Intervention: Comparison of noncontact and applanation methods
Number of subjects: 60
Study 11709252 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 60
Study 9118750 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic pouch anastomosis
Number of subjects: 46
Study 9118750 — intervention group
Group type: COMPARATOR
Intervention: Straight anastomosis
Number of subjects: 46
Study 9118750 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study 8243858 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (10‐20 mg/day)
Number of subjects: 18
Study 8243858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8243858 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 18
Study 3896661 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 10% clotrimazole cream
Number of subjects: 111
Study 3896661 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily application of 2% clotrimazole cream for 3 days
Number of subjects: 111
Study 30171345 — intervention group
Group type: EXPERIMENTAL
Intervention: High viscosity glass ionomer cement (GIC)
Number of subjects: 568
Study 30171345 — intervention group
Group type: EXPERIMENTAL
Intervention: Compomer (COM)
Number of subjects: 568
Study 30171345 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass carbomer (CAR)
Number of subjects: 568
Study 30171345 — intervention group
Group type: COMPARATOR
Intervention: Comparison between GIC and COM
Number of subjects: 568
Study 30171345 — intervention group
Group type: COMPARATOR
Intervention: Comparison of CAR with GIC and COM
Number of subjects: 568
Study 29797150 — intervention group
Group type: EXPERIMENTAL
Intervention: Child and Adolescent Services Assessment (CASA)
Number of subjects: 72